Glucocorticoids Plus Tocilizumab May Improve Respiratory Outcomes in COVID-19-Related Cytokine Storm Syndrome
Researchers assessed the effect of treatment with glucocorticoids and tocilizumab in patients with severe COVID-19-associated cytokine storm syndrome.